Clinical Trial Detail

NCT ID NCT02986178
Title PVSRIPO With/Without Lomustine
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istari Oncology, Inc.
Indications

malignant glioma

Therapies

Lomustine + PVSRIPO

PVSRIPO

Age Groups: adult senior

No variant requirements are available.